{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:11:15Z","timestamp":1787065875520,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Long non-coding RNAs (lncRNAs) are master regulators of gene expression and have recently emerged as potential innovative therapeutic targets. The deregulation of lncRNA expression patterns has been associated with age-related and noncommunicable diseases in the bone tissue, including osteoporosis and tumors. However, the specific role of lncRNAs in physiological or pathological conditions in the bone tissue still needs to be further clarified, for their exploitation as therapeutic tools. In the present study, we evaluate the potential of the lncRNA CASC2 as a regulator of osteogenic differentiation and mineralization. Results show that CASC2 expression is decreased during osteogenic differentiation of human bone marrow-derived Mesenchymal Stem\/Stromal cells (hMSCs). CASC2 knockdown, using small interfering RNA against CASC2 (siCASC2), increases the expression of the late osteogenic marker Bone Sialoprotein (BSP), but does not impact ALP staining level nor the expression of early osteogenic transcripts, including RUNX2 and OPG. Although siCASC2 does not impact hMSC proliferation nor apoptosis, it promotes the mineralization of hMSC cultured under osteogenic-inducing conditions, as shown by the increase of calcium deposits. Mass spectrometry-based proteomic analysis revealed that 89 proteins are regulated by CASC2 at late osteogenic stages, including proteins associated with bone diseases or anthropometric and musculoskeletal traits. Specifically, the Cartilage Oligomeric Matrix Protein (COMP) is highly enhanced by CASC2 knockdown at late stages of osteogenic differentiation, at both transcriptional and protein level. On the other hand, inhibition of COMP impairs osteoblasts mineralization as well as the expression of BSP. The results indicate that lncRNA CASC2 regulates late osteogenic differentiation and mineralization in hMSC via COMP and BSP. In conclusion, this study suggests that targeting lncRNA CASC2 could be a potential approach for modulating bone mineralization.<\/jats:p>","DOI":"10.3389\/fbioe.2023.1155596","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T14:17:39Z","timestamp":1688480259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization"],"prefix":"10.3389","volume":"11","author":[{"given":"Jaime","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Reis","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Adolfo","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana G.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.matbio.2014.06.001","article-title":"Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: Interaction, regulation and role in chondrogenesis","volume":"37","author":"Acharya","year":"2014","journal-title":"Matrix Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.18632\/oncotarget.6589","article-title":"miR-195 in human primary mesenchymal stromal\/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis","volume":"7","author":"Almeida","year":"2016","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e12409","DOI":"10.1111\/cpr.12409","article-title":"Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a","volume":"51","author":"Ba","year":"2018","journal-title":"Cell Prolif."},{"key":"B4","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/joe-20-0428","article-title":"Regulation of mineralisation in bone and vascular tissue: A comparative review","volume":"248","author":"Bourne","year":"2021","journal-title":"J. Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.matbio.2017.12.014","article-title":"Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis","volume":"67","author":"Coustry","year":"2018","journal-title":"Matrix Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jor.1100180506","article-title":"Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts","volume":"18","author":"Di Cesare","year":"2000","journal-title":"J. Orthop. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.22074\/cellj.2015.513","article-title":"Different methylation patterns of RUNX2, OSX, DLX5 and BSP in osteoblastic differentiation of mesenchymal stem cells","volume":"17","author":"Farshdousti Hagh","year":"2015","journal-title":"Cell J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.3390\/ijms20143430","article-title":"Genetically engineered-MSC therapies for non-unions, delayed unions and critical-size bone defects","volume":"20","author":"Freitas","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bone.2007.04.191","article-title":"Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro","volume":"41","author":"Gordon","year":"2007","journal-title":"Bone"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2741\/3875","article-title":"Biomineralization of bone: A fresh view of the roles of non-collagenous proteins","volume":"16","author":"Gorski","year":"2011","journal-title":"Front. Biosci. (Landmark Ed."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3892\/ijmm.2017.3142","article-title":"Distal-less homeobox 5 is a master regulator of the osteogenesis of human mesenchymal stem cells","volume":"40","author":"Heo","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"BSR20182454","DOI":"10.1042\/bsr20182454","article-title":"LncRNA CASC2 is up-regulated in osteoarthritis and participates in the regulation of IL-17 expression and chondrocyte proliferation and apoptosis","volume":"39","author":"Huang","year":"2019","journal-title":"Biosci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2013.03.007","article-title":"Cartilage oligomeric matrix protein enhances osteogenesis by directly binding and activating bone morphogenetic protein-2","volume":"55","author":"Ishida","year":"2013","journal-title":"Bone"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/jbmr.4147","article-title":"The musculoskeletal Knowledge portal: Making omics data useful to the broader scientific community","volume":"35","author":"Kiel","year":"2020","journal-title":"J. Bone Min. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3892\/mmr.2017.8080","article-title":"The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma","volume":"17","author":"Lu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1002\/jcb.28025","article-title":"LncRNA CASC2 inhibits proliferation and migration of adenocarcinoma cells via miR-4735-3p and mTOR","volume":"120","author":"Luo","year":"2018","journal-title":"J. Cell Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","article-title":"PANTHER version 16: A revised family classification, tree-based classification tool, enhancer regions and extensive API","volume":"49","author":"Mi","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"115303","DOI":"10.1016\/j.bone.2020.115303","article-title":"miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation","volume":"134","author":"Moura","year":"2020","journal-title":"Bone"},{"key":"B21","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.matbio.2018.02.023","article-title":"Cartilage oligomeric matrix protein: COMPopathies and beyond","author":"Posey","year":"2018","journal-title":"Matrix Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e919159-1","DOI":"10.12659\/msm.919159","article-title":"Osteopontin in bone metabolism and bone diseases","volume":"26","author":"Si","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41413-019-0048-9","article-title":"Long noncoding RNAs: A missing link in osteoporosis","volume":"7","author":"Silva","year":"2019","journal-title":"Bone Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10038-003-0013-7","article-title":"Identification of cartilage oligomeric matrix protein (COMP) gene mutations in patients with pseudoachondroplasia and multiple epiphyseal dysplasia","volume":"48","author":"Song","year":"2003","journal-title":"J. Hum. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","article-title":"Long non-coding RNAs and cancer: A new frontier of translational research?","volume":"31","author":"Spizzo","year":"2012","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/bdrc.21062","article-title":"Chondrocyte hypertrophy in skeletal development, growth, and disease","volume":"102","author":"Sun","year":"2014","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12891-019-3025-y","article-title":"MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2","volume":"21","author":"Sun","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e24569","DOI":"10.1002\/jcla.24569","article-title":"Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients","volume":"36","author":"Wang","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41572-021-00289-8","article-title":"Non-union bone fractures","volume":"7","author":"Wildemann","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.7150\/jca.26458","article-title":"The value of long noncoding RNA CASC2 as a biomarker of prognosis in carcinomas: A meta-analysis","volume":"9","author":"Yan","year":"2018","journal-title":"J. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e12506","DOI":"10.1111\/cpr.12506","article-title":"CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma","volume":"51","author":"Yu","year":"2018","journal-title":"Cell Prolif."},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-019-0728-y","article-title":"Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1155596\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T14:18:12Z","timestamp":1688480292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1155596\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":33,"alternative-id":["10.3389\/fbioe.2023.1155596"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2023.1155596","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"article-number":"1155596"}}